Outcome Predictors of Pediatric Extracorporeal Cardiopulmonary Resuscitation by Kelly, Robert B. & Harrison, Rick E.
ORIGINAL ARTICLE
Outcome Predictors of Pediatric Extracorporeal
Cardiopulmonary Resuscitation
Robert B. Kelly • Rick E. Harrison
Received: 14 August 2009/Accepted: 20 January 2010/Published online: 10 February 2010
 The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract Extracorporeal cardiopulmonary resuscitation
(ECPR) allows clinicians to potentially rescue pediatric
patients unresponsive to traditional cardiopulmonary
resuscitation (CPR). Clinical and laboratory variables
predictive of survival to hospital discharge are beginning to
emerge. In this retrospective, historical cohort case series,
clinical, and laboratory data from 31 pediatric patients
(\21 years of age) receiving ECPR from March 2000 to
April 2006 at our university-afﬁliated, tertiary-care chil-
dren’s hospital were statistically analyzed in an attempt to
identify variables predictive of survival to hospital dis-
charge. Seven patients survived to hospital discharge
(23%), and 24 patients died. Survival was independent of
gender, age, and CPR duration. ECPR survival was, how-
ever, associated with a lower pre-ECPR phosphorus con-
centration (P = 0.002) and a lower pre-ECPR creatinine
concentration (P = 0.05). A classiﬁcation tree analysis,
using, in part, a pre-ECPR phosphorus concentration
threshold and a CPR ABG base excess concentration
threshold, yielded a 96% nominal accuracy of predicting
survival to hospital discharge or death. A large, multicen-
ter, prospective cohort study aimed at validating these
predictive variables is needed to guide appropriate ECPR
patient selection. This study reveals the potential survival
beneﬁt of ECPR for pediatric patients, regardless of CPR
duration prior to ECPR cannulation.
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Extracorporeal membrane oxygenation (ECMO) has been
used in cases of pediatric cardiac arrest when traditional
cardiopulmonary resuscitation (CPR) fails [2, 17, 20].
Survival using this modality has been demonstrated [2, 17,
20]. This use of ECMO, also known as extracorporeal
cardiopulmonary resuscitation (ECPR), allows clinicians to
potentially rescue patients unresponsive to traditional CPR.
In addition, not only does ECPR provide possibly desirable
cardiopulmonary rest, but also ECPR may be used to
bridge patients to subsequent orthotopic heart transplanta-
tion [2, 16, 17] or a ventricular assist device [16].
The Extracorporeal Life Support Organization (ELSO)
maintains an extensive registry of ECMO recipients.
Collected data include demographic information, cannu-
lation details, and ECMO complications [10, 11].
According to the 2004 ELSO report, 151 neonatal cases
and 282 pediatric cases of ECPR had been entered into the
registry [7]. Among these cases, the neonatal ECPR sur-
vival rate to discharge was 43%, and the pediatric ECPR
survival rate to discharge was 39%. In a recent review of
pediatric ECPR, Thiagarajan et al. note that, between
1992 and 2005, there have been a total of 682 ECPR
patients entered into the ELSO registry, with an overall
survival rate of 38% [20].
Since ECPR typically requires signiﬁcant medical and
ﬁnancialresources,theneedforjudiciouspatientselectionis
paramount. Similarly, since ECPR may cause signiﬁcant
morbidity, the ability to predict, prior to cannulation, which
pediatric patients would beneﬁt from ECPR and survive to
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edge,thisretrospective,historicalcohortcaseseriesisoneof
the most inclusive and comprehensive analyses of multiple
clinical and laboratory variables aimed at identifying
appropriate pediatric candidates for ECPR. Although ELSO
collects a signiﬁcant amount of pediatric ECPR data, a
numberofcriticaldataﬁeldsarenotcollectedbytheregistry
[10, 11].
The primary objective of this study is to identify clinical
and laboratory variables predictive of survival to hospital
discharge among pediatric patients suffering cardiac arrest
and receiving subsequent ECPR. The secondary objective
of this study is to analyze ECPR complications and out-
comes. We hypothesized that the duration of CPR, per-
formed by adequately trained health-care providers, has no
effect on survival to hospital discharge in cases of pediatric
ECPR. In addition, we hypothesized that the degree of
acidosis prior to ECPR, as a measure of adequate ventila-
tion and oxygen delivery, is inversely related to survival to
hospital discharge.
Materials and Methods
This study was approved by the University of California,
Los Angeles (UCLA), Institutional Review Board. The
requirement for research informed consent was waived.
Mattel Children’s Hospital UCLA is a university-afﬁli-
ated, tertiary-care children’s hospital within UCLA Medi-
cal Center. All pediatric ECMO patients are cared for in a
neonatal, pediatric, or cardiothoracic intensive care unit. A
dedicated pediatric ECMO rapid response team does not
exist within UCLA Medical Center. Cardiothoracic sur-
gery, pediatric surgery, and perfusion services, however,
are readily available for consultation. ECMO cannulation is
possible in multiple locations throughout the hospital.
All patients were identiﬁed from perfusion records
maintainedbyCardiacPerfusionServicesatUCLAMedical
Center. Medical records from all pediatric ECMO patients
(\21 years of age) between March 2000 and April 2006
were screened. Demographic, clinical, and laboratory data
were collected and analyzed only from those patients
receiving ECPR, as deﬁned by ELSO [12]. According to
ELSO, ‘‘ECPR denotes Extracorporeal Cardiopulmonary
Resuscitation, in which ECLS [extracorporeal life support]
was used as part of the initial resuscitation from cardiac
arrest. Patients who are hemodynamically unstable and
placed on ECLS emergently without a cardiac arrest are
NOT considered ECPR.’’ Cardiac arrest was deﬁned as the
need for chest compressions or direct, open-chest cardiac
massage. Demographic, clinical, and laboratory data were
recorded on a data abstraction tool approved by the UCLA
Institutional Review Board.
Demographic data included each patient’s age, gender,
and underlying diagnosis. Laboratory data included the last
serum sodium, potassium, chloride, bicarbonate, ionized
calcium, magnesium, phosphorus, glucose, blood urea
nitrogen, creatinine, and hemoglobin concentrations, as
well as the last white blood cell and platelet counts,
hematocrit, and arterial blood gas (ABG) results measured
prior to, but not more than 24 h before, ECMO initiation.
In addition, arterial blood gas data (worst values) obtained
during CPR prior to ECMO initiation were collected.
Clinical data included CPR duration, ECMO duration,
ECMO complications, and survival to discharge. CPR
duration was calculated from the time of initiation of chest
compressions or direct, open-chest cardiac massage to the
time of initiation of ECMO ﬂow. ECMO duration was
calculated from the time of initiation of ECMO ﬂow to the
time of ECMO ﬂow discontinuation. Data from those
patients for whom optimal ECMO ﬂow could not be
mechanically maintained were still included in the analysis
if ECMO ﬂow had been initially established.
The P values for comparing continuous variables were
computed using the nonparametric Wilcoxon rank-sum
test. The P value for comparing gender was computed
using Fisher’s exact test. A receiver operator characteristic
(ROC)/discriminant analysis (nonparametric) was per-
formed for each continuous variable to determine the best
numerical threshold for predicting death (sensitivity) and
survival to hospital discharge (speciﬁcity). The observed
accuracy of predicting either death or survival to hospital
discharge was calculated by averaging each variable’s
threshold sensitivity and speciﬁcity. Some continuous
variables had skewed distributions on their original scale
and were, therefore, examined on a logarithmic scale. For
those variables with accuracies C80%, P values for com-
paring the proportions above the identiﬁed ROC/discrimi-
nant analysis thresholds were computed using Fisher’s
exact test.
Multivariate modeling utilized classiﬁcation tree analy-
sis, a specialized use of classiﬁcation and regression tree
analysis [4, 15]. In our study, classiﬁcation tree analysis,
utilizing binary recursive partitioning, was used to divide
study patients into either survivor or nonsurvivor groups by
analyzing all variables (except gender and ECMO dura-
tion) and selecting those variables, along with their
respective thresholds, which maximized the overall tree’s
accuracy in predicting either survival to hospital discharge
or death. Patients with missing data are still included in
classiﬁcation tree analyses, but grouping proceeds after an
analysis of alternate variables. Classiﬁcation tree analysis
allows for the identiﬁcation of multiple variables and their
respective thresholds, which, together, may improve the
accuracy of predicting either death or survival to hospital
discharge greater than any single variable alone. Each
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123subsequent generation of nodes in a classiﬁcation tree is the
product of identifying the best variable and its respective
threshold with the lowest P value from among those sub-
jects in the immediately preceding node. This process is
repeated each time a new generation of nodes is produced,
such that only the subjects comprising the immediately
preceding node are analyzed, not the original group of
subjects on which the ﬁrst split was made in the classiﬁ-
cation tree. Therefore, although univariate or ROC/dis-
criminant analyses may identify predictive variables one at
a time while ignoring the other variables, classiﬁcation
trees identify predictive variables only from among those
subjects comprising an individual node on which a new
split is made. The classiﬁcation tree, therefore, identiﬁes
predictive variables while controlling for (not ignoring)
other variables previously identiﬁed.
Statistical analyses were performed utilizing SAS 9.1
(SAS Institute, Inc., Cary, NC) and Answer Tree 3.0 (SPSS
Inc., Chicago, IL).
Results
Between March 2000 and April 2006, 31 pediatric patients
at Mattel Children’s Hospital UCLA received ECPR. The
majority of ECPR recipients had a history of recent car-
diothoracic surgery for a range of congenital cardiac
defects (18 patients). Remaining patients had a history of
remote cardiovascular surgery (six patients), cardiomyop-
athy (ﬁve patients), myocarditis (one patient), or pulmon-
ary hypertension (one patient) (Table 1). Twenty-ﬁve
patients suffered cardiac arrest in an intensive care unit,
two patients in an operating room, one patient in the
emergency department, one patient in a procedure room,
one patient in a catheterization suite, and one patient on the
inpatient ward. Of these 31 patients, 7 survived to hospital
discharge (23% survival), and 24 patients died. Survivor
and nonsurvivor groups did not differ according to gender
(P = 0.74) (Table 2).
Survivors to hospital discharge were statistically similar
in age compared to nonsurvivors at the time of their cardiac
arrest (median, 356 vs. 28 days; P = 0.07). CPR duration
did not differ between survivors and nonsurvivors (median,
40 vs. 47 min; P = 0.30; range, 24–75 vs. 5–101 min). For
two nonsurvivors, CPR initiation times were adjusted to a
later time during the analysis due to an inability to pre-
cisely identify in the medical record the exact minute CPR
was started. These two adjustments were judged to be
minimal. Survivors and nonsurvivors were also found to
have similar ECMO durations (median, 4 vs. 2 days;
P = 0.15) (Table 3).
Survivors had signiﬁcantly lower pre-ECMO serum
phosphorus concentrations compared to nonsurvivors
(median, 4.65 vs. 6.85 mg/dl; P = 0.002). After log age
adjustment, pre-ECMO serum phosphorus concentrations
remained signiﬁcantly lower among survivors (median,
4.96 vs. 6.70 mg/dl; P = 0.01). In addition, serum creati-
nine concentrations were lower among survivors (median,
0.6 vs. 0.8 mg/dl; P = 0.05). Other laboratory variables
did not appear to be associated with survival on bivariate
analysis (Table 4).
Using ROC/discriminant analysis, pre-ECMO serum
phosphorus concentration was found to be the most accu-
rate variable predictive of survival to hospital discharge or
death (threshold, 5.5 mg/dl; sensitivity, 80%; speciﬁcity,
100%; accuracy, 90%; P = 0.001), with a lower serum
phosphorus concentration being associated with survival.
Other highly accurate variables predictive of survival to
hospital discharge included CPR ABG pCO2 concentration
(threshold, 76 mm Hg; sensitivity, 67%; speciﬁcity, 100%;
accuracy, 83%; P = 0.08), with a lower CPR ABG pCO2
concentration being associated with survival, and CPR
ABG bicarbonate concentration (threshold, 16.7 mmol/l;
sensitivity, 60%; speciﬁcity, 100%; accuracy, 80%;
Table 1 Medical history of ECPR recipients (N = 31)
Medical history Survivors Nonsurvivors
Recent cardiothoracic surgery 4 14
Remote cardiothoracic surgery 1 5
Cardiomyopathy 1 4
Myocarditis 1 0
Pulmonary hypertension 0 1
Note: ECPR, extracorporeal cardiopulmonary resuscitation
Table 2 Gender of ECPR recipients
Gender Survivors Nonsurvivors
Male 4 12
Female 3 12
Total 7 24
Note: ECPR, extracorporeal cardiopulmonary resuscitation
Table 3 Group comparison of clinical characteristics
Variable Survivors Nonsurvivors P
value
No. Median Mean No. Median Mean
Age (days) 7 356 1549 24 28 629 0.07
CPR duration
(min)
7 40 46 23 47 54 0.30
ECMO duration
(days)
7 4 4 24 2 6 0.15
Note: CPR cardiopulmonary resuscitation, ECMO extracorporeal
membrane oxygenation
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123P = 0.19), with a higher CPR ABG bicarbonate concen-
tration being associated with survival.
A classiﬁcation tree analysis, using, in part, a pre-ECPR
phosphorus concentration threshold of 5.5 mg/dl and
a CPR ABG base excess concentration threshold of
–13 mmol/l, yielded a sensitivity of 92%, a speciﬁcity of
100%, and a nominal accuracy of predicting survival to
hospital discharge or death of 96% (Fig. 1), with a lower
pre-ECMO phosphorus concentration and a greater (integer
value) CPR ABG base excess concentration associated
with survival.
Upon reviewing ECPR complications and outcomes,
following ECMO cannulation ﬁve patients (16%) were
found to have developed a new intracranial hemorrhage by
radiographic or autopsy evidence. None of these patients
survived to discharge. In addition, optimal ECMO ﬂow
could not be mechanically maintained for three patients
(10%). None of these patients survived to discharge. Three
patients were ultimately declared brain dead. ECPR
bridged one patient to orthotopic heart transplantation and
ultimate survival to hospital discharge. In addition, ECPR
successfully rescued one myocarditis patient who ulti-
mately survived to hospital discharge.
Discussion
ECPR is a potentially lifesaving intervention, but one that
carries signiﬁcant risks. To our knowledge, this retro-
spective, historical cohort case series is one of the most
inclusive and comprehensive analyses of multiple clinical
and laboratory variables aimed at identifying appropriate
pediatric candidates for ECPR.
Survival
Three recent reports have examined pediatric ECPR
survival predictors [2, 13, 20]. Thiagarajan et al. have
Table 4 Group comparison of laboratory characteristics
Laboratory test Survivors Nonsurvivors P value
No. Median Mean No. Median Mean
Sodium (mmol/l) 7 143.0 141.1 24 145.0 145.7 0.32
Potassium (mmol/l) 7 4.4 4.5 24 4.4 4.4 0.85
Chloride (mmol/l) 7 104 104 24 106 106 0.21
Bicarbonate (mmol/l) 7 22.0 23.0 24 21.0 22.3 0.45
Ionized calcium (mmol/l) 6 1.16 1.25 22 1.33 1.36 0.26
Magnesium (mEq/l) 7 2.0 2.0 22 1.9 1.9 0.63
Phosphorus (mg/dl) 6 4.7 4.6 20 6.9 6.8 0.002
Glucose (mg/dl) 5 230 206 23 174 197 0.72
Blood urea nitrogen (mg/dl) 7 10 11 23 12 16 0.20
Creatinine (mg/dl) 7 0.6 0.6 23 0.8 0.8 0.05
White blood cell count (91,000) 7 11.3 10.6 20 12.4 12.8 0.41
Hemoglobin (g/dl) 7 13.3 12.9 18 13.0 12.9 0.86
Hematocrit (%) 7 39.4 38.8 22 36.3 37.7 0.68
Platelet count (91,000) 7 168 166 20 123 145 0.32
Prothrombin time (s) 6 14.6 14.7 16 16.8 24.7 0.21
Activated partial thromboplastin time (s) 6 34.8 55.4 16 43.7 68.4 0.42
International normalized ratio 6 1.4 1.5 16 1.6 2.1 0.32
Pre-CPR ABG pH 4 7.33 7.31 22 7.20 7.21 0.36
Pre-CPR ABG pCO2 (mm Hg) 4 44 47 22 49 58 0.75
Pre-CPR ABG pO2 (mm Hg) 4 45 89 22 53 86 0.67
Pre-CPR ABG HCO3
- (mmol/l) 4 22.2 22.2 19 21.6 20.6 0.63
Pre-CPR ABG base excess (mmol/l) 4 –4.5 –4.0 22 –4.5 –6.0 0.72
CPR ABG pH 3 7.27 7.25 12 7.13 7.11 0.42
CPR ABG pCO2 (mm Hg) 3 54 51 12 97 89 0.22
CPR ABG pO2 (mm Hg) 3 43 103 12 35 89 0.31
CPR ABG HCO3
- (mmol/l) 3 21.0 20.4 10 15.1 19.5 0.50
CPR ABG base excess (mmol/l) 3 –7.0 –6.3 12 –14.0 –9.5 0.39
Note. CPR, cardiopulmonary resuscitation; ABG, arterial blood gas
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123reviewed the largest series of pediatric ECPR cases known
[20]. According to their report, the overall survival of all
pediatric ECPR patients in the ELSO registry between
1992 and 2005 was 38%. The survival rate among those
patients receiving ECPR for cardiac reasons was 42%.
Although our survival rate is lower, our patients’ illness
severity and complexity of disease may not be comparable
to those of patients in the ELSO registry. The majority of
our patients had recent cardiothoracic surgery.
Although Alsouﬁ et al. have reviewed the second largest
series of pediatric ECPR cases known, pre-ECMO labo-
ratory variables were not examined [2]. Our data, however,
are consistent with the ﬁnding that gender does not affect
survival to hospital discharge. Furthermore, our survival
rate to hospital discharge, although lower, is comparable
(23 vs. 34%). In another report, Huang and colleagues
reviewed a series of 26 pediatric ECPR patients, including
a number of clinical and laboratory variables [13]. A higher
survival rate (41%) was reported, despite our similar ECPR
specialist availability and patient population.
The higher survival rate reported by Alsouﬁ et al. [2]i s
likely unrelated to the presence of an in-house ECMO spe-
cialist and/orperfusionistatalltimesatthe Hospital forSick
Children in Toronto. Although UCLA Medical Center dif-
fersinthatanECMOperfusionistisnotin-houseatalltimes,
our CPR duration times are very similar to those reported by
Alsouﬁ and colleagues. In the report by Alsouﬁ et al.,
however, ECPR is considered within 10 min of starting
CPR.Likewise,ourCPRdurationswerealsosimilartothose
reported by Huang and colleagues [13], but they had dis-
cussed the possible advantages of ECPR with staff, and the
goal was to activate ECPR for appropriate patients after
10–15 min of refractory CPR. Although the survival beneﬁt
of a rapid response ECMOteamdoes not appear statistically
evident upon analysis of a report by Duncan et al. [9], this
may be related to the small number of patients analyzed.
Mattel Children’s Hospital UCLA does not have an
ofﬁcial policy outlining the requirements needed to initiate
ECPR. We speculate that educating staff and having a goal
of activating or at least considering ECPR for appropriate
patients early during CPR may introduce a selection bias.
In other words, a physician may reject a potential ECPR
candidate earlier due to a probable irreversible reason for
the cardiac arrest. By then selecting a patient for ECPR
because of a probable reversible reason for the cardiac
arrest, the physician may be improving his or her institu-
tion’s ECPR survival rate. We also speculate that educating
staff and having a goal of activating or at least considering
ECPR for appropriate patients early during CPR may
improve or expedite the delivery of ancillary care, such as
antibiotic or blood product administration. Although fur-
ther investigation is needed to conﬁrm these hypotheses,
we speculate that being familiar with the potential advan-
tages of ECPR and educating staff should, at least intui-
tively, improve ultimate survival to discharge.
Phosphorus
Pre-ECMOserumphosphorusconcentrationwasfoundtobe
signiﬁcantly lower among survivors to hospital discharge,
even after log age adjustment. In addition, ROC/discrimi-
nant analysis identiﬁed the pre-ECMO serum phosphorus
concentration as the most accurate continuous variable in
predicting survival to hospital discharge or death. To our
knowledge, these ﬁndings have not been reported previ-
ously.Wefurthernotethatserumphosphorusconcentrations
among survivors to hospital discharge were not lower due to
dialysis, as survivors to hospital discharge were not receiv-
ing dialysis at the time of their arrest.
We speculate that a serum phosphorus concentration in a
compromised cardiac output state may be inversely related
to a patient’s metabolic reserve, as supported by Ku-
priyanov et al. in a porcine model of myocardial ischemia
[14]. Increased phosphorus has also been observed in dogs
(subjected to cardiac arrest) during CPR and following
circulatory return [3]. Furthermore, increased phosphorus
has also been seen after giving lactic acid to dogs [19]. The
fact that speciﬁc CPR ABG pCO2 and bicarbonate con-
centration thresholds were also found to be highly accurate
in predicting survival to hospital discharge or death by
ROC/discriminant analysis lends support to this metabolic
31 Patients
Phosphorus
> 5.5 mg/dL
No Yes
7 Survivors
6 Non-survivors
0 Survivors
18 Non-survivors
0 Survivors
4 Non-survivors
7 Survivors
2 Non-survivors
Yes No
CPR Arterial Base Excess
> -13 mmol/L
Fig. 1 Classiﬁcation tree analysis of all variables (except gender and
extracorporeal membrane oxygenation [ECMO] duration). Patients
with missing data are included, but grouping proceeded after an
analysis of alternate variables. The use, in part, of a pre-ECMO
phosphorus concentration and a cardiopulmonary resuscitation (CPR)
arterial base deﬁcit concentration could predict survival to discharge
or death with a nominal accuracy of 96%
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123theory. Furthermore, a classiﬁcation tree analysis, using, in
part, a pre-ECPR phosphorus concentration threshold of
5.5 mg/dl and a CPR ABG base excess concentration
threshold of –13 mmol/l, yielded a highly accurate model
of predicting ECPR survival to hospital discharge or death,
with a lower pre-ECMO phosphorus concentration and a
higher CPR ABG base excess concentration associated
with survival. Empirically, adequate ventilation, cardiac
output, and end-organ perfusion, as reﬂected in normal
CPR ABG pCO2, bicarbonate, and base excess concentra-
tions, should be associated with patient survival. In other
words, inadequate ventilation, cardiac output, and end-
organ perfusion typically lead to acidemia from an
increased pCO2 concentration and a decreased bicarbonate
concentration as reﬂected in a decreased base excess con-
centration. Our ﬁndings regarding CPR ABG pCO2,
bicarbonate and base excess concentrations are consistent
with this theory with regard to survival to discharge. This
unexpected ﬁnding regarding phosphorus, however,
requires validation.
Creatinine
Pre-ECMO creatinine concentration was found to be lower
among survivors to hospital discharge (P = 0.05). One
possible explanation for this ﬁnding is that a higher cre-
atinine concentration represents pre-CPR compromised
end-organ perfusion. Therefore, higher creatinine concen-
trations may reﬂect patients more susceptible to further
impaired cardiac output during resuscitation.
Our ﬁnding conﬂicts, however, with other published
reports and, therefore, requires validation. In a pediatric
ECPR report by Huang and colleagues, the prevalence of
‘‘renal failure’’ (as deﬁned by a low urine output or a fall in
creatinine clearance) after ECMO initiation was signiﬁ-
cantly higher among nonsurvivors despite its having been
similar prior to CPR. [13]. In another report, although
Allan and colleagues found no difference in blood urea
nitrogen or creatinine concentrations between survivors
and nonsurvivors in their study of pediatric ECMO use
associated with cardiac catheterization, 3 patients among
their study population of 22 were not ECPR recipients [1].
CPR Delivery
ROC/discriminant analysis is a powerful statistical tool
which identiﬁes thresholds for continuous variables in cases
ofdichotomous outcomes,whilemaximizingsensitivityand
speciﬁcity. This analysis may be particularly useful in clin-
ical situations, where clinicians might be presented with a
particular laboratory value and desire to predict the likeli-
hood of one of two possible outcomes. ROC/discriminant
analysis of our data, in addition to identifying a pre-ECMO
phosphorus concentration threshold, also identiﬁed CPR
ABG pCO2 and CPR ABG bicarbonate concentration
thresholds as highly accurate predictors of survival to hos-
pital discharge or death. Both CPR ABG pCO2 and CPR
ABG bicarbonate concentrations likely reﬂect the adequacy
of resuscitative ventilation, cardiac output, and end-organ
perfusion and, thereby, the effectiveness of CPR in our
patient population. This conclusion, however, is only spec-
ulative and requires further investigation. Similarly, the
identiﬁcation of a pre-ECMO phosphorus concentration
threshold and a CPR arterial base excess concentration
threshold in the multivariate analysis also supports our
speculation that effective CPR is the major contributor to
ECPR survival to discharge. For as discussed earlier, inad-
equate ventilation, cardiac output, and end-organ perfusion
typically lead to acidemia from an increased pCO2 concen-
tration and a decreased bicarbonate concentration as reﬂec-
ted in a decreased base excess concentration. Our ﬁndings
regarding CPR ABG pCO2, bicarbonate, and base excess
concentrations are consistent with this theory with regard to
survival to discharge. These laboratory tests may be surro-
gatesforobjectivemeasurementsofCPRperformance,such
as chest compression depth or ventilation frequency. Fur-
thermore, by extension, those patients undergoing ineffec-
tive CPR may suffer proportionately more end-organ
damage during CPR, thereby increasing their likelihood of
mortalitydespitehavingsurvivedcannulation.Interestingly,
similar to our results, pre-ECPR acid–base status does
appeartobeassociatedwithsurvivalaccordingtoareportby
Thiagarajan and colleagues [20]. ECPR survivors tended to
have a lower pre-ECMO ABG pCO2 concentration
(P = 0.06) and a signiﬁcantly higher pre-ECMO ABG pH
(P = 0.001).
CPR Duration
Whether CPR duration inﬂuences survival to discharge
following ECPR is controversial. Two recent pediatric
reports have shown that CPR duration is not signiﬁcantly
associated with death [2, 17]. Our CPR duration times are
comparable to these reports. Huang et al., however, showed
a signiﬁcant association between longer CPR duration and
death among pediatric ECPR recipients [13]. In their
report, ECPR ‘‘activation time’’ (‘‘time from cardiac arrest
to calling the ECMO team’’) took signiﬁcantly longer for
those patients who ultimately did not survive. In addition, a
large adult ECPR study has indicated that a CPR duration
\60 min is signiﬁcantly associated with survival [6]. Our
series would suggest that CPR duration does not affect
survival to discharge among pediatric patients receiving
ECPR. We speculate that this may be due to the fact that
effective CPR depends, in part, on qualiﬁed providers,
adequate vascular access, ready availability of resuscitation
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123medications and equipment, and optimal hemodynamic
monitoring. These are typically present in tertiary-care
settings, such as ours. As a result, we speculate that CPR
duration is likely less important to ECPR survival to dis-
charge than the effectiveness of that CPR, perhaps reﬂected
by, as we speculate, CPR ABG pCO2, bicarbonate, and
base excess concentrations, for example. This is only a
hypothesis, however, requiring further investigation.
ECMO Duration
ECMO duration did not differ signiﬁcantly between sur-
vivors to hospital discharge and nonsurvivors. This ﬁnding
is consistent with other reports [2, 5, 13, 17]. At our
institution, although the timing of ECMO decannulation
procedures varied widely and an intracranial hemorrhage is
generally a contraindication to ECMO continuation, this
ﬁnding may indicate that providing adequate pre-ECMO
oxygen delivery affects overall survival to hospital dis-
charge more than the ECMO course, itself, and any ECMO
complications.
ROC/Discriminant Analysis
As noted previously, ROC/discriminant analysis is a
powerful statistical tool which identiﬁes thresholds for
continuous variables in cases of dichotomous outcomes,
while maximizing sensitivity and speciﬁcity and, thereby,
accuracy. This analysis is provided as an alternative and,
perhaps, more clinically relevant way to analyze our ECPR
data as opposed to traditional univariate distribution com-
parisons. P values computed for continuous univariate and
ROC/discriminant analyses, respectively, may not be
equivalent since ROC/discriminant analysis, unlike tradi-
tional univariate analysis, identiﬁes an actual threshold that
maximizes accuracy. ROC/discriminant analysis, therefore,
may be particularly useful in clinical situations where cli-
nicians are presented with a particular laboratory value and
desire to predict the likelihood of one of two possible
outcomes. ROC/discriminant analysis can, therefore, real-
istically guide clinical decisions at the bedside during
ECPR candidate evaluation, especially if the threshold for
the variable in question has a high accuracy. ROC/dis-
criminant analysis can potentially provide useful informa-
tion that can guide clinical decisions when variables with
high accuracy have been identiﬁed. Our ﬁndings, however,
ﬁrst require validation.
Limitations
Our retrospective, historical cohort case series has a
number of limitations potentially affecting the ability to
generalize our ﬁndings to other institutions, providers, and
patients. Our study population, although largely homoge-
neous, was relatively small. A larger sample size may be
required to see larger or additional differences between
survivors to hospital discharge and nonsurvivors. Also, all
of our patients suffered in-hospital cardiac arrests, which
are associated with improved survival to discharge, com-
pared to out-of-hospital arrests [8, 18, 21]. Furthermore,
multiple medical providers were involved in the care of
these patients, and variations in medical and surgical care
undoubtedly occurred, before, during, and after cannula-
tion. We also did not analyze any potentially available
follow-up records, including neurological and develop-
mental evaluations. Finally, the number of physicians who
rejected potential ECPR candidates due to probable irre-
versible reasons for their cardiac arrest (selection bias) is
unknown.
Conclusions
ECPR is a potentially lifesaving intervention, but one that
carries signiﬁcant risks. Lower pre-ECMO phosphorus and
creatinine concentrations were associated with survival to
hospital discharge in our patients. Furthermore, CPR arte-
rial pCO2, bicarbonate, and base excess concentration
thresholds may aid in the prediction of patient survival to
discharge or death.
We believe that a large, multicenter, prospective cohort
study is required to sufﬁciently validate whether these pre-
ECPR variables or others are predictive of survival to hos-
pital discharge. Selection bias, however, may be difﬁcult to
eliminate.Suchastudycouldpotentiallyidentifydifferences
amongcertainsubgroupsofpatientswithspeciﬁcdiagnoses.
Additional data ﬁelds should be collected as well.
We strongly caution against generalizing these ﬁndings
to other patients. Validation of these results and further
investigation are needed. At the very least, this study
provides statistical methods and a framework for analyzing
this clinical dilemma. Given the interplay of many vari-
ables and the complexity of human physiology, a multi-
variate model is likely to provide the most guidance.
Fortunately, the laboratory variables found to be associated
with survival to hospital discharge in this report are readily
available in the modern medical setting. Given the limita-
tions discussed, however, pediatric cardiologists, intensi-
vists, and surgeons should continue to rely on clinical
judgment when evaluating potential ECPR recipients. As
our data support, ECPR should remain an option to health-
care providers in cases of refractory pediatric cardiac
arrest, even if CPR duration is lengthy.
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